(Temple University) Angiocidin, a tumor-inhibiting novel protein, may also have a role as a new therapeutic application in treating leukemia by inducing a differentiation of monocytic leukemia cells into a normal, macrophage-like phenotype.
Tumor-inhibiting protein could be effective in treating leukemiaCourtesy EurekAlert! - Medicine and Health Mon, 07/14/2008 - 23:00
(Temple University) Angiocidin, a tumor-inhibiting novel protein, may also have a role as a new therapeutic application in treating leukemia by inducing a differentiation of monocytic leukemia cells into a normal, macrophage-like phenotype. More related itemsLab study shows methadone breaks resistance in untreatable...
Math could help cure leukemia
Combination of 2 novel anti-cancer agents may help fight CML...
New drug combination brings 1-2 punch against acute leukemia
Just Do It: How One Couple Turned Off the TV and Turned On...
Lovely by Sarah Jessica Parker Perfume for Women
A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...
|
Popular by tags WeekMonth |
Post new comment